World exotic diseases

Biological Invasions: Economic and Environmental Costs of Alien Plant, Animal, and Microbe Species

Volumn , Issue , 2014, Pages 331-354

  Kim, Yoonji ^a  

^a Plant Breeding and Genetics Section in the School of Integrative Plant Science   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85152349302     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420041668-30     Document Type: Chapter

References (151)

1. Gao, Feng., et al. Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature, 397, 436-441 (1999).
2. Hirsch, V.M., et al. An African primate lentivirus (SIVsm) closely related to HIV-2. Nature, 339, 389-392 (1989).
3. Vandamme, A.M., et al. Dating HIV and HCV epidemics with a new method to uncover clock-like molecular evolution: HIV-1 group M originated during the 1930s (Abstract). XIII International AIDS Conference in Durban, South Africa. 9-14 July 2000, www.iac2000.org (Retrieved 31 July 2001).
4. Joint United Nations Programme on HIV/AIDS, AIDS epidemic update: December 2000. Geneva, Switzerland.
5. Joint United Nations Programme on HIV/AIDS, Report on the global HIV/AIDS epidemic June 2000. Geneva, Switzerland.
6. National Institute of Allergy and Infectious Diseases (National Institute of Health and US Department of Health and Human Servies). NIAID Global Health Research Plan for HIV/AIDS, Malaria and Tuberculosis. www.niaid.nih.gov/default.htm (Retrieved on 10 June 2001).
7. World Health Organization. Affordable AIDS drugs are within reach. Note for the Press No.2: 14 February 2001. www.who.int/inf-pr-2001/en/note2001-02.html (Retrieved on 22 June 2001).
8. World Health Organization. WHO welcomes US announcement to contribute US$200 million to a global HIV/AIDS health fund. WHA 54/3:14 May 2001. www.who.int/inf-pr-2001/en/note2001-WHA3.html (Retrieved in 22 June 2001).
9. Smith, Davis N., AIDS watch. Pharmaceutical Executive, 21, 132 (2001).
10. Schwärtlander, B., et al. Resource needs for HIV/AIDS. Science, 292, 2434-2436 (2001).
11. Bloom, David E., et al. Something to be done: treating HIV/AIDS. Science, 288, 2171-2172 (2000).
12. Mutume, Gumisai, Pressure mounts for cheaper anti-AIDS treatment. Population Reference Bureau. February 2001. www.prb.org/regions/africa/pressure.html (Retrieved on 8 June 2001).
13. South African Department of Health, HIV/AIDS/STD Strategic Plan for South Africa 2000-2005. www.doh.gov.za/aids/index.html (Retrieved on 10 June 2001).
14. The impending catastrophe: a resource book on the emerging HIV/AIDS epidemic in South Africa. Abt Associates of South Africa, Inc. The Henry J. Kaiser Family Foundation. www.kff.org/content/2000/20000515a/ (Retrieved on 10 June 2001).
15. Karim, Salim S. Abdool., HIV and TB. Lancet, 349, 1542-1543 (1997).
16. Smith, Anthony M.A., et al. Australian and South African undergraduates’ HIV-related knowledge, attitudes and behaviors. Archives of Sexual Behavior 27, 279-294 (1998).
17. Cohen, Jon., Ground zero: AIDS research in Africa. Science, 288, 2150-2153 (2000).
18. Hwang, Ann., AIDS has arrived in China and India. World Watch, 14, 12-20 (2001).
19. Population Reference Bureau., Only 4 out of 10 Indian Women have heard of AIDS. www.prb.org/press/HIV_AIDS/Indian_Women_AIDS.html (Retrieved on 8 June 2001).
20. Sharma, Dinesh, India to develop an AIDS vaccine. Lancet, 357, 1024 (2001).
21. Centers for Disease Control and Prevention. HIV prevention strategic plan through 2005, January 2001. www.cdc.gov/hiv/dhap.htm (Retrieved on 1 August 2001).
22. Center for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2000, 12 (no.2) [5, 14, 27, 30] www.cdc.gov/hiv/stats/hasr1202.htm (Retrieved on 1 August 2001).
23. Sekles, Flavia, Brazil’s needle-exchange programs reduce HIV risk for drug users. Population Reference Bureau, 2001 www.prb.org/regions/lac/Brazil_Needle.html. (Retrieved on 2 June 2001).
24. Ministry of Health Brazil. AIDS Drug Policy. www.aids.gov.br/assistencia/ aids_drugs_policy.html (Retrieved on 20 June 2001).
25. Yamey, Gavin, U.S. trade action threatens Brazilian AIDS programme. BMJ, 322, 7283 (2001).
26. Public Health Laboratory Service. HIV/AIDS and STD Surveillance in the United Kingdom. www.phls.co.uk/facts/hiv/old/hivold.htm (Retrieved on 1 June 2001).
27. Unlinked Anonymous Surveys Steering Group. Prevalence of HIV and hepatitis infections in the United Kingdom 1999. London; Department of Health, Public Health Laboratory Service, Institute of Child Health (London), Scottish Centre for Infection and Environmental Health. 2000 www.phls.co.uk/facts/HIV/UAPMP (Retrieved on 1 June 2001).
28. Commonwealth Department of Health and Family Services. Partnerships in Practice: National HIV/AIDS Strategy 1996-1997 to 1998-1999(December 1996). Australian Department of Health and Aged Care. www.health.gov.au/hfs/pubhlth/publicat/hac.htm. (Retrieved on 2 June 2001).
29. Public Health Laboratory Service. PHLS CDSC HIV/AIDS CORE SLIDE SET. www.phls.co.uk/facts/yfever.htm (Retrieved on 1 June 2001).
30. Wodak, Alex and Lurie, Peter., A tale of 2 countries. Journal of Drug Issues, 27, 117-134 (1997).
31. Walford, Diana and Noah, Norman., International Editors. Emerging Infectious Diseases, 5 (online), London; Public Health Laboratory Service (1999). www.cdc.gov/ncidod/ eid/vol5no2/walford.html (Retrieved on 20 June 2001).
32. Lichtenstein, Bronwen., Tradition and Experiment in New Zealand AIDS policy. AIDS and Public Policy Journal, 12, 79-88 (1997).
33. Ministry of Health., AIDS and New Zealand, 39 November 1998. www.moh.govt.nz (Retrieved on 9 June 2001).
34. Bloom, Barry R. and Murray, Christopher J.L., Tuberculosis: commentary on reemergent killer. Science, 257, 1055-1064 (1992).
35. Tynes, L Lee., Tuberculosis: The continuing story. JAMA, 270, 2616-2617 (1993).
36. Fackelman, Kathleen., Tuberculosis outbreak. Science News, 153, 73-75 (1998).
37. Manchester, Keith., Tuberculosis and leprosy: evidence for interaction of disease in Human Paleopathology, Aufderheide, Arthur C. and Ortner, Donald J. (Eds.), Smithsonian Institution Press, Washington, 1991, 23.
38. Kapur, V., Whittman, T.S., and Musser, J.M., Is Mycobacterium tuberculosis 15, 000 years old? J Infect Dis, 170, 1348-1349 (1994).
39. Daniel, T.M., The origins and precolonial epidemiology of tuberculosis in the Americas: can we figure them out? Int J Tuberc Lung Dis, 4, 395-400 (2000).
40. Salo, Wilmar L.I., et al. Identification of Mycobacterium tuberculosis DNA in a pre-Columbian Peruvian mummy., Proc. Natl. Acad. Sci., 91, 2091-2094 (1994).
41. Gibbons, A., The peopling of the Americas. Science News, 274, 31-33 (1996).
42. Hurtago de Mendoza, D. and Braginiski, R.Y., Y chromosomes point to native American Adam. Science, 283, 1439-1440 (1999).
43. Wiess, K.M., American origins. Proc. Natl. Acad. Sci., 91, 833-835 (1994).
44. World Health Organization. Global Tuberculosis Control. WHO Report 2001. Geneva, Switzerland, WHO/CDS/TB/2001.287 (Retrieved 30 May 2001)
45. Revised National TB Control Programme (RNTCP). TB India. Central TB Control, Directorate General of Health Services, Ministry of Health and Family Welfare. www.tbcindia.org (Retrieved on 16 June 2001).
46. De Cock, Kevin M. and Dworkin, Mark S., HIV infection and TB. World Health, 51, 14 (1998).
47. World Health Organization. Tuberculosis. WHO Fact Sheet 2000 N°104. Geneva, Switzerland. www.who.int/gtb (Retrieved on 30 May 2001).
48. World Health Organization. HIV causing tuberculosis cases double in Africa (Press Release WHO/21:23 April 2001). Geneva, Switzerland. www.who.int/inf/pr-2001/en/pr2001.html (Retrieved on 30 May 2001).
49. World Health Organization. WHO and STOP TB launch new initiative to increase access to free TB drugs: The Global TB Drug Facility (Press Release WHO/13:20 March 2001). Geneva, Switzerland. www.who.int/inf-pr-2001/en/pr2001/-13.html (Retrieved on 30 May 2001).
50. World Health Organization. $1.5 billion need to meet TB control targets in highest burden countries (Press Release WHA 54/3: 16 May 2001). Geneva, Switzerland. www.who.int/gtb/press/index.htm (Retrieved on 30 May 2001).
51. STOP TB. Country Profiles. www.stootb.org (Retrieved on 13 June 2001).
52. Fourie, Bernard., TB in South Africa-The burden of tuberculosis in South Africa. MRC National Tuberculosis Research Programme, South Africa. www.sahealthinfo.org/Publications/ body_tb/body_body_tb.htm (Retrieved on 4 June 2001).
53. Global Corps. South Africa. www.globalcorps.com/orgs/ngo/dotw/safrica.html (Retrieved on 4 June 2001).
54. Walford, Diana and Noah, Norman., Emerging Infectious Diseases, 5 (online), London; Public Health Laboratory Service (1999). www.cdc.gov/ncidod/eid/vol5no2/walford.html (Retrieved on 20 June 2001).
55. Hayward, A.C., and Watson, J.M., Tuberculosis in England and Wales, 1982 to 1993:Notifications exceeded predictions. Comm Dis Rep CDR Review, 5, 29-33 (1995).
56. Public Health Laboratory Service., Press Release 26 January 2001. www.phls.co.uk/new/pressreleases/01pr/010126.htm (Retrieved on 20 June 2001).
57. Public Health Laboratory Service., Tuberculosis Briefings. www.phls.co.uk/facts/tb/briefing. htm (Retrieved on 20 June 2001).
58. Joint Tuberculosis Committee of the British Thoracic Society (BTS). Control and prevention of tuberculosis in the United Kingdom: Code of Practice 2000. Thorax, 55, 887-901 (2000).
59. Sheldon, C.D., et al. Notification of tuberculosis:how many cases are never reported? Thorax, 47, 1015-1018 (1993).
60. Evans, Meirion R., Is tuberculosis taken seriously in the United Kingdom? BMJ, 311, 1483-1485 (1995).
61. Csillag, Claudio., Bonuses proposed for TB cures in Brazilian health centres. Lancet, 352, 1453 (1998).
62. Pan American Health Organization (PAHO). Brazil: Basic country profiles: summaries 1999. www.paho.org/SHA/prflbra.html (Retrieved on 30 July 2001).
63. Pan American Health Organization (PAHO). The use of socioeconomic factors in mapping tuberculosis risk areas in a city of northeastern Brazil. Pan American Journal of Public Health (online), 8, December 2000. www.paho.org/English/DVI/ES.v8n6.html (Retrieved on 17 June 2001).
64. Queensland Government-Queensland Hovernment-Queensland Health. Tuberculosis in Australia and New Zealand into the 1990s. www.health.qld.gov.au/phs/shs/CONAUS19900202v1.htm (Retrieved on 13 June 2001).
65. Dawson, David., Tuberculosis in Australia: bacteriologically confirmed cases and drug resistance, 1996. WHO Collaborating Centre in Tuberculosis Bacteriology, Queensland Health Pathology Services, Brisbane. www.health.gov.au.pubhlth/cdi/cdi2209/cdi2209.htm (Retrieved on 13 June 2001).
66. Isaacs, David and Mellis, Craig M., Tuberculosis in children in Australia: strategies for control. MJA, 168, 121-124 (1998).
67. Mycobacterium Reference Laboratory. The Australian Tuberculosis Project. www.vidrl.org.au/mrl/atb.htm (Retrieved on 13 June 2001).
68. Ministry of Health. No room for complacency about TB in New Zealand says Ministry of Health. Media Release: 24 March 2001.www.moh.govt.nz (Retrieved on 13 June 2001).
69. Ministry of Health. World TB Day is a reminder that the disease still exists. Media Release: 26 March 2001. www.moh.govt.nz (Retrieved on 13 June 2001).
70. New Zealand Health Information Service (NZHIS). Health Statistics. www.nzhis.govt.nz/stats/diseases/tuberculosis.html (Retrieved on 13 June 2001).
71. Escalante, Ananias A. and Ayala, Francisco., Evolutionary origin of Plasmodium and other Apicomplexa based on rRNA genes. Proc. Natl. Acad. Sci., 92, 5793-5797 (1995).
72. Escalante, Ananias A. and Ayala, Francisco., Phylogeny of the malarial genus Plasmodium, derived from rRna gene sequences. Proc. Natl. Acad. Sci., 91, 11373-11377 (1994).
73. Escalante, Ananias A., et al. The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome. Proc. Natl Acad. Sci., 95, 8124-8129 (1998).
74. Conway, David J., Origin of Plasmodium falciparum malaria is traced by mitochondrial DNA. Molecular and Biochemical Parasitology, 111, 163-171 (2000).
75. World Health Organization. Malaria. Fact Sheet No 94: 1998 October. www.who.int/inffs/ en/fact094.html (Retrieved on 24 July 2001).
76. Roll Back Malaria (RBM). www.rbm.who.int (Retrieved on 25 July 2001).
77. Kapp, Clare., WHO wins reprieve for DDT against malaria. Lancet, 356, 2076 (2000).
78. Yamey, G., Global campaign to eradicate malaria. BMJ, 322, 1191-1192 (2001).
79. Dua, V.K., et al. Chloroquine resistant Plasmodium vivax malaria in India. Tropical Medicine and International Health, 1, 816-819 (1996).
80. Sharma, V.P., Re-emergence of malaria in India. Indian Journal of Medical Research, 103, 26-45 (1996).
81. Jayaraman, K.S., India plans $200 million attack on malaria. Nature, 386, 536 (1997).
82. Pan American Health Organization (PAHO). Situation of malaria programs in the Americas. www.paho.org/English/SHA/be_v22n1-malaria.htm (Retrieved on 22 July 2001).
83. Lucia, Ana., et al. High prevalence of asymptomatic malaria in gold mining areas in Brazil. Clinical Infectious Diseases, 12, 79-88 (1997).
84. Milliken, William., Malaria and antimalarial plants in Roraima, Brazil. Tropical Doctor, 27 (suppl), 20-25 (1997).
85. Akhavan, Dariush., et al. Cost-effective malaria control in Brazil-cost-effectiveness of a malaria control program in the Amazon Basin of Brazil, 1988-1996. Social Science and Medicine, 49, 1385-1399 (1999).
86. D’ A Gusmao, Renato., Cost-effective control in Brazil. World Health, 51, 30 (1998).
87. South African Department of Health. Malaria: current situation in South Africa. www.doh.gov.za/pr/1996/pr0308b.html (Retrieved on 22 July 2001).
88. South African Department of Health. Statistics Notes. 2 (2000). www.doh.gov/za/search/index. html (Retrieved on 22 July 2001).
89. Anon. Malaria costs Africa $300 billion. African Business, 255, 28 (2000).
90. Medical Research Council of South Africa. MIM:A global movement against malaria. www.mrc.ac.za.mrcnews/jun99/mim.html (Retrieved on23 July 2001).
91. Jenkin-Grant, A., et al. Airport malaria in Cairns. MJA, 166, 307-308 (1997).
92. Walker, John., Malaria in the changing world: an Australian perspective. International Journal of Parasitology, 28, 947-953 (1998).
93. Robinson, Priscilla., Imported malaria treated in Melbourne, Australia: Epidemiology and clinical features in 246 patients. J Travel Med, 8, 76-81 (2001).
94. Australia’s notifiable disease status, 1998. Communicable Disease Intelligence, 23 (1998). www.health.gov.au:80/hfs/pubhlth/cdi/cdi2311/cdi2311g.htm (Retrieved on 25 July 2001).
95. Bryan, Joan H., Malaria transmission and climate change in Australia. MJA, 164, 345-347 (1996).
96. Orchard, Valerie, et al. The communicable disease picture in New Zealand today. Healthcare Review Online, 4 (2000). www.enigma.co.nz.hcro_articles/0005/vol4no5_001.htm (Retrieved on 24 July 2001).
97. Bradley, D.J. and Bannister, B., Guidelines for malaria prevention in travelers from the United Kingdom for 2001. Communicable Disease and Public Health, 4, 84-101 (2001).
98. Deb, B.C., Epidemiology of cholera in India and its treatment and control. Current Science, 59, 702-707 (1990).
99. Sanyal, Suhas C., Cholera in its present day scenario. Journal of the Indian Medical Association, 98, 371-376 (2000).
100. World Resources Institute. Cholera returns. World Resources 1998-1999. www.wri.org/wri/wr-98-99/cholera.html (Retrieved on 26 July 2001).
101. Cowell, Rita R., Global climate and infectious diseases: the cholera paradigm. Science, 274, 2025-2031 (1996).
102. World Health Organization. Global surveillance of epidemic-prone infectious diseases. Geneva, Switzerland. WHO/CDS/CSR/2000.1. www.who.int (Retrieved on 30 May 2001).
103. World Health Organization. Potential use of oral cholera vaccines in emergency situtations: report of a WHO meeting. Geneva, Switzerland. WHO/CDS/CSR/EDC/99.4 www.int/gtb (Retrieved on 30 May 2001).
104. Shimada, T., et al. Outbreak of Vibrio cholerae non-01 in Bangladesh. Lancet, 341, 1347 (1993).
105. World Health Organization. Cholera, 2000. Weekly Epidemiological Record, 76, 233-240 (2001).
106. World Health Organization. Cholera, 1999. Weekly Epidemiological Record, 75, 249-256 (2000).
107. Morris, Kelly., Prevention fails to halt South Africa’s well-treated cholera epidemic. Lancet, 357, 290 (2001).
108. Sidley, Pat., Cholera sweep throughout South Africa province. BMJ, 322, 71-71 (2001).
109. Sur, D., et al. Severe cholera outbreak following floods in a northern district of West Bengal. Indian Journal of Medical Research, 112, 178-182 (2000).
110. Pan American Health Organization (PAHO). Number of cholera cases in the Americas 1991-2000. www.paho.org/English/HCP/HCT/Cholera_cases_1991-2000.htm (Retrieved on 2 September 2001).
111. Tauxe, Robert., et al. Epidemic cholera in the new world-translating field epidemiology into new prevention strategies. Emerging Infectious Diseases, 1 (online), 141-146 (1995). www.cdc.gov/ncidod/eid/vol1no4/tauxe.htm (Retrieved on 1 August 2001).
112. Taubenberger, J.K., et al. Initial genetic characterization of the 1918 ‘Spanish’ influenza virus. Science, 275, 1793-1796 (1997).
113. World Health Organization. Influenza A (H5N1): fact sheet no. 188. www.who.int/inffs/ en/fact094.html (Retrieved on 13 July 2001).
114. World Health Organization. The WHO influenza programme: fact sheet no. 212. www.who.int/inf-fs/en/fact212.html (Retrieved on 13 July 2001).
115. Webster, R.G., et al. Evolution and ecology of influenza A viruses. Microbiology, 56, 159-179 (1992).
116. World Health Organization. WHO report on global surveillance of epidemic-prone infectious diseases. WHO/CDS/CSR/ISR/2000.1 Geneva, Switzerland (Retrieved on 13 July 2001).
117. Reid, Ann H., et al. Origin and evolution of the 1918 “Spanish” influenza virus hemagglutinon gene. Proc. Natl. Acad., 96, 1651-1656 (1999).
118. Smith, Rosalind Stanwell., The search for permafrost and other victims of the 1918 influenzacommentary. Health and Hygiene, 22, 9-13 (2001).
119. World Health Organization. Content of 2002 “Southern Hemisphere” influenza vaccine decided. Press Release WHO/41 18 September 2001. www.who.int/inf-pr-2001/en/pr2001-41.html (Retrieved on 19 September 2001).
120. Frequently asked questions. International Influenza Education Panel. www.influenzanews. com (Retrieved on 5 August 2001).
121. National Foundation for Infectious Diseases (NFID). Facts about influenza for adults. www.nfid.org/factsheets/influadult.html (Retrieved on 5 August 2001).
122. Wiselka, M., Influenza:diagnosis, management, and prophylaxis. BMJ, 308, 1341-1345 (1994).
123. Thomson, Jennifer, Ling, Ming and Hampson, Alan., Annual report of the National Influenza Surveillance Scheme. Comm. Dis. Intell., 24, 145-152 (2000).
124. Jennings, Lance., Influenza surveillance and immunisation in New Zealand, 1990-1999, New Zealand Public Health Report, 8, 9-16 (2001).
125. World Health Organization. Hepatitis A. WHO/CDS/CSR/EDC/2000.7. Geneva, Switzerland. www.who.int/emc (Retrieved on 5 July 2001).
126. Simmonds, P., The origin and evolution of hepatitis viruses in humans. Journal of General Virology, 82, 693-712 (2001).
127. Arauz-Ruiz, P., et al. Genotype F prevails in HBV infected patients of Hispanic origin in Central America and may carry the precore stop mutant. Journal of Medical Virology, 51, 305-312 (1997).
128. Norder H., Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, for of which represent two new genotypes. Virology, 198, 489-503 (1994).
129. MacDonald, D.M., et al. Detection of hepatitis B virus infection in wild-born chimpanzees (Pan troglodytes verus): phylogenetic relationships with human and other primate genotypes. Journal of Virology, 74, 4253-4257 (2000).
130. Lemon, S.M., Type A viral hepatitis: epidemiology, diagnosis, and prevention. Clinical Chemistry, 43, 1494-1499 (1997).
131. André, F.E., Approaches to a vaccine against hepatitis A: development and manufacture of an inactivated vaccine. Journal of Infectious Diseases, 171 (suppl 1), S33-S39 (1995).
132. Tormans, G., et al. Cost-effectiveness analysis of hepatitis A prevention in travelers. Vaccine, 10 (suppl 1), S88-S92 (1992).
133. Berge, J.J., et al. The cost of hepatitis A infections in American adolescents and adults in 1997. Hepatology, 31, 469-473 (2000).
134. Karim, A., et al. Sero-epidemiology of hepatitis A in black South African children. SAMJ, 83, 748-750 (1993).
135. Sathar, M.A., et al. Racial differences in the sero-prevalence of hepatitis A virus infection in Natal/KwaZulu, South Africa. Journal of Medical Virology, 44, 9-12 (1994).
136. Fleet, G.H., et al. Foodborne viral illnesses:status in Australia. International Journal of Food Microbiology, 59, 127-136 (2000).
137. Stokes, M.L., Outbreak of Hepatitis A among homosexual men in Sydney. American Journal of Public Health, 87, 2039-2041 (1997).
138. Dick, A., et al. Persisting hepatitis A infection in a central Queensland town. Comm. Dis. Intell., 18, 83-89 (1994).
139. Amin, J., et al. Hepatitis A epidemiology in Australia: national seroprevalence and notifications. Medical Journal of Australia, 174, 338-341 (2001).
140. World Health Organization. Hepatitis B: Fact sheet WHO/204. www.int/inffs/ en/fact204.html (Retrieved on 5 July 2001).
141. Irshad, M., et al. Prevalence of hepatitis B virus infection in healthy person in North India. Natl. Med.J. India., 7, 210-212 (1994).
142. Tandon, B.N., et al. Epidemiology of hepatitis B virus infection in India. Gut, 38 (suppl 2), S56-S59 (1996).
143. Tandon, B.N., et al. Etiological spectrum of viral hepatitis and prevalence of markers of hepatitis A and B virus infection in North India. Bulletin of WHO, 62, 67-73 (1984).
144. Balogun, M.A., et al. Acute hepatitis B infection in England and Wales: 1985-96. Epidemiological Infections, 122, 125-131 (1999).
145. Fenn, P., et al. An economic evaluation of universal vaccination against hepatitis B virus. Journal of Infection, 32, 197-204 (1996).
146. Souto, F.J.D., Epidemiological survey of infection with hepatitis B virus in the savannah and wetlands (Pantanal) of central Brazil. Annals of Tropical Medicine and Parasitology, 91, 411-416 (1997).
147. Kew, M.C., Progress towards the comprehensive control of hepatitis B in black South African children. SAMJ, 83, 748-750 (1993).
148. Vos, G.H., et al. Hepatitis B antigen and antibodies in rural and urban southern African blacks. South African J. Med., 57, 868-870 (1984).
149. Kaldor, J.M., et al. The incidence of hepatitis B infection in Australia: an epidemiological review. Medical Journal of Aust., 165, 322-326 (1996).
150. Anon. Global surveillance and control of hepatitis C. Journal of Viral Hepatitis, 6, 35-47 (1999).
151. World Health Organization. Hepatitis C: fact sheet no.164. www.who.int/inffs/ en/fact164.html (Retrieved on 19 July 2001).